Probability of Payment

No definition available.

Name:	stj_ProbabilityofPayment
Namespace Prefix:	stj_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure fair value. For example, but not limited to, weighted average cost of capital (WACC), cost of capital, cost of equity and cost of debt.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)
-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name:	us-gaap_FairValueInputsDiscountRate
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name:	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Details

Name:	us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FairValueByLiabilityClassAxis=stj_ContingentConsiderationLiabilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=stj_NanostimMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=stj_RevenueBasedMilestonesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ValuationTechniqueAxis=us-gaap_IncomeApproachValuationTechniqueMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=stj_ThoratecCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=stj_RegulatoryandRevenueBasedMilestoneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=stj_SpinalModulationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=stj_RegulatoryBasedMilestonesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=stj_RevenueBasedMilestonesandEarnOutsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ValuationTechniqueAxis=us-gaap_MarketApproachValuationTechniqueMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Fair Value Measurements and Financial Instruments (Contingent Consideration Liabilities) (Details) - Fair Value, Inputs, Level 3 [Member] - USD ($) $ in Millions	12 Months Ended
	Jan. 02, 2016	Jan. 03, 2015	Dec. 28, 2013	Dec. 29, 2012
Contingent Consideration Liability [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Contingent Consideration Liabilities	$ 151	$ 50	$ 195	$ 0
Nanostim [Member] \| Contingent Consideration Liability [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Contingent Consideration Liabilities	$ 2	50	56	0
Nanostim [Member] \| Revenue Based Milestones [Member] \| Probability Weighted Discounted Cash Flow [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Discount Rate	5.00%
Probability of Payment	10.00%
Nanostim [Member] \| Revenue Based Milestones [Member] \| Contingent Consideration Liability [Member] \| Probability Weighted Discounted Cash Flow [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Contingent Consideration Liabilities	$ 2
Thoratec [Member] \| Contingent Consideration Liability [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Contingent Consideration Liabilities	$ 27	0	0	0
Thoratec [Member] \| Regulatory and Revenue Based Milestone [Member] \| Probability Weighted Discounted Cash Flow [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Discount Rate	5.50%
Thoratec [Member] \| Regulatory and Revenue Based Milestone [Member] \| Probability Weighted Discounted Cash Flow [Member] \| Minimum [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Probability of Payment	0.00%
Thoratec [Member] \| Regulatory and Revenue Based Milestone [Member] \| Probability Weighted Discounted Cash Flow [Member] \| Maximum [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Probability of Payment	90.00%
Thoratec [Member] \| Regulatory and Revenue Based Milestone [Member] \| Contingent Consideration Liability [Member] \| Probability Weighted Discounted Cash Flow [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Contingent Consideration Liabilities	$ 27
Spinal Modulation [Member] \| Contingent Consideration Liability [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Contingent Consideration Liabilities	$ 122	$ 0	$ 0	$ 0
Spinal Modulation [Member] \| Regulatory Based Milestones [Member] \| Probability Weighted Discounted Cash Flow [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Discount Rate	2.10%
Probability of Payment	95.00%
Spinal Modulation [Member] \| Regulatory Based Milestones [Member] \| Contingent Consideration Liability [Member] \| Probability Weighted Discounted Cash Flow [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Contingent Consideration Liabilities	$ 118
Spinal Modulation [Member] \| Revenue-Based Milestones and Earn-Outs [Member] \| Monte Carlo Simulation [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Probability of Payment	25.00%
Spinal Modulation [Member] \| Revenue-Based Milestones and Earn-Outs [Member] \| Monte Carlo Simulation [Member] \| Minimum [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Discount Rate	1.30%
Spinal Modulation [Member] \| Revenue-Based Milestones and Earn-Outs [Member] \| Monte Carlo Simulation [Member] \| Maximum [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Discount Rate	17.00%
Spinal Modulation [Member] \| Revenue-Based Milestones and Earn-Outs [Member] \| Contingent Consideration Liability [Member] \| Monte Carlo Simulation [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Contingent Consideration Liabilities	$ 4